enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Anecortave acetate - Wikipedia

   en.wikipedia.org/wiki/Anecortave_acetate

   Anecortave / æ n ə ˈ k ɔːr t eɪ v / is a novel angiogenesis inhibitor used in the treatment of the exudative (wet) form of age-related macular degeneration.Although similar in chemical structure to the corticosteroid hydrocortisone acetate, it possesses no glucocorticoid activity. [1]

3. Macular Society - Wikipedia

   en.wikipedia.org/wiki/Macular_Society

   The Macular Society is a UK [1] [2] charity that offers support to anyone affected by central vision loss.. Many of the charity's members have age-related macular degeneration (AMD), but its services are open to people with various retinal conditions, including myopic macular degeneration, diabetic retinopathy, and inherited retinal dystrophies like Stargardt disease, Best disease, and Sorsby ...

4. BrightFocus Foundation - Wikipedia

   en.wikipedia.org/wiki/BrightFocus_Foundation

   BrightFocus Foundation is a nonprofit organization based in Clarksburg, Maryland.BrightFocus funds research in an effort to discover cures for Alzheimer's disease, macular degeneration and glaucoma, and provides information and free English and Spanish resources to increase awareness about these diseases.

5. Geographic atrophy - Wikipedia

   en.wikipedia.org/wiki/Geographic_atrophy

   Fundus of geographic atrophy. Geographic atrophy (GA), also known as atrophic age-related macular degeneration (AMD) or advanced dry AMD, is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retinal tissue (photoreceptors, retinal pigment epithelium, choriocapillaris) which can lead to a loss of central vision over time.

6. National Eye Institute - Wikipedia

   en.wikipedia.org/wiki/National_Eye_Institute

   Comparison of Age-Related Macular Degeneration Treatments Trial: Lucentis-Avastin Trial: This two-year, multicenter clinical trial compared the effectiveness of two treatments used for AMD: Lucentis and Avastin. It showed that both treatments are equally effective in treating AMD and improving vision, whether used monthly or as needed.

7. Macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Macular_degeneration

   The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]